Description : |
Enables tumor necrosis factor receptor binding activity. Involved in several processes, including T cell activation; regulation of gene expression; and regulation of lymphocyte activation. Acts upstream of or within cholesterol metabolic process; inflammatory response; and negative regulation of cytokine production. Predicted to be located in cell surface. Predicted to be active in extracellular space. Is expressed in sensory organ and skeleton. Used to study primary pulmonary hypertension and type 1 diabetes mellitus. Human ortholog(s) of this gene implicated in myocardial infarction. Orthologous to human TNFSF4 (TNF superfamily member 4). |
Source : |
HEK293 |
Species : |
Mouse |
Tag : |
Fc |
Form : |
Lyophilized |
Molecular Mass : |
44.5 kDa |
Protein Length : |
198 |
AA Sequence : |
MEGEGVQPLDENLENGSRPRFKWKK TLRLVVSGIKGAGMLLCFIYVCLQL SSSPAKDPPIQRLRGAVTRCEDGQL FISSYKNEYQTMEVQNNSVVIKCDG LYIIYLKGSFFQEVKIDLHFREDHN PISIPMLNDGRRIVFTVVASLAFKD KVYLTVNAPDTLCEHLQINDGELIV VQLTPGYCAPEGSYHSTVNQVPL |
Purity : |
> 98% |
Applications : |
WB; ELISA; FACS; FC |
Stability : |
This bioreagent is stable at 4 centigrade (short-term) and -70 centigrade(long-term). After reconstitution, sample may be stored at 4 centigrade for 2-7 days and below -18 centigrade for future use. |
Storage : |
At -20 centigrade. |
Concentration : |
1 mg/mL |
Storage Buffer : |
PBS (pH 7.4-7.5). Sterile-filtered colorless solution. |
Reconstitution : |
Reconstitute in sterile distilled H2O to no less than 100 μg/mL; dilute reconstituted stock further in other aqueous solutions if needed. Please review COA for lot-specific instructions. Final measurements should be determined by the end-user for optimal performance. |